Macugen ( EyetechPharmaceuticals and Pfizer ), which is based onaptamer binding a human vascular endothelial growth factor (VEGF), has beencertified as an efficient drug for the treatment of age-related macular degeneration[9, 10]. Here, VEGFA is linked to age-related macular degeneration.